BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 23532105)

  • 1. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
    Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
    Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
    Rossi RE; Burroughs AK; Caplin ME
    Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
    Lerut JP; Orlando G; Adam R; Schiavo M; Klempnauer J; Mirza D; Boleslawski E; Burroughs A; Sellés CF; Jaeck D; Pfitzmann R; Salizzoni M; Söderdahl G; Steininger R; Wettergren A; Mazzaferro V; Le Treut YP; Karam V;
    Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.
    Gedaly R; Daily MF; Davenport D; McHugh PP; Koch A; Angulo P; Hundley JC
    Arch Surg; 2011 Aug; 146(8):953-8. PubMed ID: 21844436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review.
    Bonaccorsi-Riani E; Apestegui C; Jouret-Mourin A; Sempoux C; Goffette P; Ciccarelli O; Borbath I; Hubert C; Gigot JF; Hassoun Z; Lerut J
    Transpl Int; 2010 Jul; 23(7):668-78. PubMed ID: 20478000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
    van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
    Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is liver transplantation as surgical therapy concept in metastases of neuroendocrine tumors justified?].
    Lang H; Oldhafer KJ; Schlitt HJ; Scheumann GF; Ringe B; Pichlmayr R
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():416-8. PubMed ID: 9101890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure?
    De Carlis L; Di Sandro S; Giacomoni A; Mangoni I; Lauterio A; Mihaylov P; Cusumano C; Rampoldi A
    J Clin Gastroenterol; 2013 Apr; 47(4):352-8. PubMed ID: 23188072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
    Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
    Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary treatment strategy for advanced pancreatic neuroendocrine tumors- a single center experience.
    Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Sichinohe T
    Hepatogastroenterology; 2012; 59(120):2623-6. PubMed ID: 22497945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.
    Elias D; Goéré D; Leroux G; Dromain C; Leboulleux S; de Baere T; Ducreux M; Baudin E
    Eur J Surg Oncol; 2009 Oct; 35(10):1092-7. PubMed ID: 19464140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
    Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
    Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
    Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O
    Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
    Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
    Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
    Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
    Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
    Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for primary or secondary endocrine tumors.
    Gregoire E; Le Treut YP
    Transpl Int; 2010 Jul; 23(7):704-11. PubMed ID: 20492617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.